Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.30% | 194.67 | 1.2% | $552.50m | |
| TSRO | TESARO, Inc. | 0.16% | 74.21 | 14.4% | $550.20m | |
| CELG | Celgene Corporation | 0.12% | 68.76 | 1.2% | $525.72m | |
| GILD | Gilead Sciences, Inc. | -0.06% | 67.45 | 0.9% | $512.93m | |
| BIIB | Biogen Inc. | -0.11% | 319.08 | 1.3% | $359.12m | |
| ILMN | Illumina, Inc. | 0.72% | 325.38 | 3.5% | $356.81m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.98% | 373.91 | 2.6% | $258.98m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.17% | 171.74 | 1.9% | $239.02m | |
| A | Agilent Technologies, Inc. | 0.43% | 70.89 | 1.5% | $238.56m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.61% | 113.95 | 2.0% | $141.38m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.90% | 123.90 | 15.4% | $115.15m | |
| INCY | Incyte Corporation | -0.35% | 65.19 | 2.5% | $106.04m | |
| EXAS | Exact Sciences Corporation | -0.42% | 69.26 | 25.3% | $101.47m | |
| NKTR | Nektar Therapeutics | -2.11% | 35.89 | 5.5% | $97.96m | |
| EXEL | Exelixis, Inc. | -1.73% | 20.99 | 6.4% | $83.45m |
Company Profile
Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.